SCHEMBL5752628

SCHEMBL5752628

O=C(O)C(Cc1ccc(OC(F)(F)C(F)F)cc1)C(O)c1ccc(F)cc1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.42
PPARG P37231 2/20 0.41
PPARA Q07869 2/20 0.41
KMT2A Q03164 1/20 0.40
ALDH1A1 P00352 1/20 0.40
TSHR P16473 1/20 0.40
HSD17B10 Q99714 1/20 0.40
CNR1 P21554 2/20 0.40
NR4A2 P43354 1/20 0.37
FPR2 P25090 1/20 0.37
ACE P12821 1/20 0.36
FFAR1 O14842 1/20 0.36
CPA1 P15085 1/20 0.36
CETP P11597 1/20 0.36
GPR34 Q9UPC5 1/20 0.35
LMNA P02545 1/20 0.35
GAA P10253 1/20 0.35
TRPV1 Q8NER1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5753436 0.90 PTPN1 (0.44) PTPN1PPARGPPARAKMT2ACNR1
SCHEMBL5748762 0.86 CETP (0.46) PPARGPPARACETP
SCHEMBL5755188 0.84 KMT2A (0.39) PPARGPPARAKMT2AALDH1A1ACE
SCHEMBL5752733 0.84 KMT2A (0.48) PPARGPPARAKMT2AALDH1A1TSHR
SCHEMBL5749180 0.82 LDHA (0.55) PPARGPPARAKMT2AALDH1A1CNR1
SCHEMBL5749815 0.82 RORC (0.36) PPARGPPARAFFAR1
SCHEMBL5749734 0.82 KMT2A (0.36) PPARGPPARAKMT2AALDH1A1ACE
SCHEMBL5751742 0.82 KMT2A (0.44) PPARGPPARAKMT2AALDH1A1TSHR
SCHEMBL5749231 0.81 PTPN1 (0.39) PTPN1PPARGPPARACNR1CETP
SCHEMBL5749813 0.81 PPARA (0.50) PPARGPPARAFFAR1GPR34

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6982348-B2 Aminoethanol derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-01-03 US disclosed
US-20040127574-A1 Aminoethanol derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-07-01 US disclosed
EP-1362846-A1 AMINOETHANOL DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-11-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040127574-A1 Aminoethanol derivatives CETP, LCAT, MTTP PTPN1 2672/4885PPARG 905/4885PPARA 708/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.